Conference Coverage

Three days of beta-lactam beat clinically stable CAP


 

REPORTING FROM ECCMID 2018

Nor does Dr. Dinh expect wholesale clinical embracing of the encouraging results, which bolster the ever-accumulating data in favor of shorter courses of antibiotics for some infectious diseases.

“I think there is a chance that clinicians who normally treat for 9 or 10 days may now feel comfortable reducing to 7,” he said with a chuckle.

The French Ministry of Health sponsored the study. Dr. Dinh had no competing financial interests.

SOURCE: Dinh et al. ECCMID 2018, Oral Abstract O1126.

Pages

Recommended Reading

Predicting MDR Gram-negative infection mortality risk
The Hospitalist
Is it time for health policy M&Ms?
The Hospitalist
Drug combo indicated for bacterial pneumonia
The Hospitalist
Paring the risk of antibiotic resistance
The Hospitalist
Reported penicillin allergies hike inpatient costs
The Hospitalist
FDA warns against clarithromycin use in patients with heart disease
The Hospitalist
Making structural improvements in health care
The Hospitalist
Unusual antibiotic resistance found in more than 200 bacteria
The Hospitalist
Don’t shorten therapy for older, sicker cellulitis patients
The Hospitalist
ESBL-resistant bacteria spread in hospital despite strict contact precautions
The Hospitalist
   Comments ()